Keith Holmes
St George's Hospital(GB)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Education Systems and Policy, Global Educational Policies and Reforms, Higher Education Learning Practices, Cancer therapeutics and mechanisms
Most-Cited Works
- → The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report(2008)1,129 cited
- → Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial(2018)383 cited
- → Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial(2017)339 cited
- → Referral patterns for specialist child and adolescent mental health services in the Republic of Ireland during the COVID-19 pandemic compared with 2019 and 2018(2021)211 cited
- → Surgical Risk Factors in Primary Surgery for Localized Neuroblastoma: The LNESG1 Study of the European International Society of Pediatric Oncology Neuroblastoma Group(2005)208 cited
- → Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)(2020)141 cited
- → Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study(2020)119 cited
- → Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without MYCN Amplification: Results of the Prospective INES 99.1(2010)107 cited
- → Image‐defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy‐induced variation, and impact on surgical outcomes(2017)104 cited
- → Challenges for Educational Research: International development, partnerships and capacity building in small states(2001)92 cited